Go to navigation Go to content
Toll-Free: (888) 606-5297
Phone: (859) 578-4444
Schachter, Hendy & Johnson, Attorneys At Law

FDA Looks to Restrict Testosterone Prescriptions and Use

Sarah N. Emery
Associate Attorney at Schachter Hendy & Johnson PSC
Posted on Sep 17, 2014

RegulationsToday the Food and Drug Administration met to consider whether it should tighten the rules for the testosterone industry. Testosterone medications, like AndroGel, were once only used by a small group of men for a select few medical conditions. After mass marketing by large pharmaceutical companies, testosterone is being prescribed to millions of American men for symptoms largely related to aging.

The FDA has said that the benefits of testosterone for healthy, aging men are unproven and testosterone could be risky. Testosterone use has been linked to many health problems: heart attack, stroke, pulmonary embolism, bone death, congestive heart failure and blood clots.

The FDA is asking its expert panel what limits it should impose on the use of testosterone. New rules issued by the FDA could reduce the number of men who are prescribed testosterone and limit the coverage for testosterone provided by insurance companies.

If you or a loved one have suffered a heart attack, stroke, pulmonary embolism, blood clot, congestive heart failure, or bone death after taking testosterone, please call our experienced AndroGel attorneys for a free consultation about your potential testosterone lawsuit.

Read More About FDA Looks to Restrict Testosterone Prescriptions and Use...

Live Chat